Autolus Therapeutics (AUTL) Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 14, 2026

Net selling: insiders sold $16K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: -$16K net
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about AUTL filings

Are insiders buying or selling Autolus Therapeutics Ltd (AUTL) stock?

Net selling: insiders sold $16K and bought $0 of AUTL stock on the open market in the 90 days to Nov 14, 2026, according to SEC Form 4 filings. The largest was Piccina, Cintia (U.S. CCO & Country Gen Manager), who sold $16K. The latest filing was on Sep 3, 2026.

Which members of Congress have traded AUTL recently?

None. No member of Congress disclosed a AUTL trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this AUTL smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

CPPiccinaInsider, filed Sep 3Sold$15.7K

Smart money on AUTL

Lean short1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
- Cintia Piccina, sold $15.7K, scheduled plan sale, filed Sep 3
Lean short · thin1 sale · $15.7K
1 of 1 on scheduled plans. Form 4 filings.
Congress
No recent politician filings found
Funds
No recent fund filings found
Influencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about AUTL filings

Are insiders buying or selling Autolus Therapeutics Ltd (AUTL) stock?

Which members of Congress have traded AUTL recently?

None. No member of Congress disclosed a AUTL trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this AUTL smart-money data?

Insiders

What insiders are doing

1 trade · 6 mo

Sold$16K

Sells (1)

PC
Piccina Cintia
U.S. CCO & Country Gen Manager · Sep 3
$16K
sold

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 10, 2026

Earnings came in 16.7% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 10, 2026

Period ending

Sep 30, 2026

Earnings per share

-$0.21-16.67% miss

-$0.18 expected

Revenue

$41.2M

SEC filing

EPS: Yahoo Finance

Next report

What the street expects next

Estimates as of Nov 13, 2026

EPS expected

-$0.17

-$0.21 to -$0.13

Revenue expected

$37.8M

6 analysts

Last 30 days

0up1down

Analysts cutting estimates

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 10, 2026	-$0.21est. -$0.18	-16.67%miss	$41.2MSEC filing	+94.6%from $21.2M
Jun 30, 2026Reported Aug 11, 2026	-$0.15est. -$0.21	+28.57%beat	$45.7MSEC filing	+118.4%from $20.9M
Mar 31, 2026Reported May 14, 2026	-$0.27est. -$0.26	-4.20%miss	$26.2MSEC filing	+191.9%from $9.0M
Dec 31, 2025Reported Mar 27, 2026	-$0.34est. -$0.27	-28.00%miss	$24.3MYahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 12, 2025	-$0.30est. -$0.23	-30.43%miss	$21.2MSEC filing	No year-ago quarter
Jun 30, 2025Reported Aug 12, 2025	-$0.18est. -$0.23	+21.74%beat	$20.9MSEC filing	No year-ago quarter
Mar 31, 2025Reported May 8, 2025	-$0.26est. -$0.26	+0.00%in line	$9.0MSEC filing	-11.0%from $10.1M
Dec 31, 2024Reported Mar 20, 2025	-$0.09est. -$0.24	+62.50%beat	$10.1M · FYSEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $1.32
High: $1.33
Low: $1.20
Prev close: $1.32
52-wk high: $2.58
52-wk low: $1.12
Mkt cap: $316.7M
ROE: -174.9%
Beta: 2.35
P/S: 2.3x
P/B: 12.0x
Profit margin: -186.4%
Op margin: -159.3%

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -186.4%
Market cap: $317M

Valuation

P/S2.31
P/B12.00

Quality

Operating margin-159.3%
ROE-174.9%
ROA-23.1%

Growth

Beta2.35

Technicals

Price structure

This stock is under pressure, and looks oversold after a sharp drop.

Trend

Under pressure

0 / 100

RSI 14

24oversold

20D volatility

62%annualized

52-week range

$1.24

$1.12$2.58

20D support

$1.12recent floor

20D resistance

$1.74recent ceiling

Returns

5D -10.5%20D -26.9%60D -46.1%

Price vs moving averages

SMA20 -17.0%SMA50 -29.1%SMA200 -25.7%

Volume pace

1.59xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Sep 30, 2026Nov 10, 2026

-$0.21est. -$0.18

-16.67%

$41.2MSEC filing

+94.6%from $21.2M

Jun 30, 2026Aug 11, 2026

-$0.15est. -$0.21

+28.57%

$45.7MSEC filing

+118.4%from $20.9M

Mar 31, 2026May 14, 2026

-$0.27est. -$0.26

-4.20%

$26.2MSEC filing

+191.9%from $9.0M

Dec 31, 2025Mar 27, 2026

-$0.34est. -$0.27

-28.00%

$24.3MYahoo Finance

No year-ago quarter

Sep 30, 2025Nov 12, 2025

-$0.30est. -$0.23

-30.43%

$21.2MSEC filing

No year-ago quarter

Jun 30, 2025Aug 12, 2025

-$0.18est. -$0.23

+21.74%

$20.9MSEC filing

No year-ago quarter

Mar 31, 2025May 8, 2025

-$0.26est. -$0.26

+0.00%

$9.0MSEC filing

-11.0%from $10.1M

Dec 31, 2024Mar 20, 2025

-$0.09est. -$0.24

+62.50%

$10.1M · FYSEC filing

No year-ago quarter

Autolus Therapeutics Ltd

Smart money at a glance

What do analysts expect?

Questions about AUTL filings

Smart money on AUTL

Questions about AUTL filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 16.7% below what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Autolus Therapeutics Ltd

Smart money at a glance

What do analysts expect?

Questions about AUTL filings

Smart money on AUTL

Questions about AUTL filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 16.7% below what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Autolus Therapeutics Ltd

Overview

Questions about AUTL filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Autolus Therapeutics Ltd

Overview

Questions about AUTL filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.